Position in NTRA
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$2,799
New position
Shares Held
14
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Abound Wealth Management holds $76,304 across 13 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
93 | $26,040 | |
| 2 | DGX |
Quest Diagnostics Inc
|
75 | $15,896 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
30 | $15,040 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
5 | $6,387 | |
| 5 | WAT |
Waters Corp /De/
|
9 | $3,375 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
6 | $3,158 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
16 | $3,091 | |
| 8 | FLGT |
Fulgent Genetics, Inc.
|
56 | $1,149 |
All Filings in NTRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,799 | 14 | Shares | Sole | 2026-04-10 | |
| No filing history on record for this holder in this stock. | ||||||